Milestone Pharmaceuticals
We are a patient-centric, clinical-stage biopharmaceutical company dedicated to bringing an investigational medication to patients living with paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation (AFib), as well as other episodic cardiovascular conditions.